Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kiyomi Araki
SHP2 Inhibition Prevents Adaptive Resistance to MEK Inhibitors in Multiple Cancer Models
Cancer Discovery
Oncology
Related publications
Shipping Out MEK Inhibitor Resistance With SHP2 Inhibitors
Cancer Discovery
Oncology
SHP2 Inhibition Overcomes RTK-mediated Pathway Re-Activation in KRAS Mutant Tumors Treated With MEK Inhibitors
Molecular Cancer Therapeutics
Cancer Research
Oncology
Acquired Resistance to BRAF Inhibition Can Confer Cross-Resistance to Combined BRAF/MEK Inhibition
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
PAK Signaling Promotes Acquired Resistance to BRAF and MEK Inhibitors
Cancer Discovery
Oncology
MEK1 Mutations Confer Resistance to MEK and B-Raf Inhibition
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
KRAS Mutation as a Resistance Mechanism to BRAF/MEK Inhibition in NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
MEK Inhibition Prevents TGF‑β1‑induced Myofibroblast Transdifferentiation in Human Tenon Fibroblasts
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Inhibition of PI3K/mTOR Leads to Adaptive Resistance in Matrix-Attached Cancer Cells
Cancer Cell
Cancer Research
Oncology
Cell Biology
Vertical Pathway Inhibition Overcomes Adaptive Feedback Resistance to KRASG12C Inhibition
Clinical Cancer Research
Cancer Research
Oncology